WilliamEFeemanJr.MD

PubMed

• Antihypertensive and Lipid–Lowering Treatment to Prevent Heart Attack Trial Recommendations for Antihypertensive Therapy
  William E. Feeman> ;The American Journal of Cardiology. 2017 Aug 1
• 1 citations
  How Low is Low Enough
  William E. Feeman> ;The American Journal of Cardiology. 2017 Mar 18
• Screening lipids in children.
  William E. Feeman> ;Journal of Clinical Lipidology. 2014 Mar 1
• 8 citations
  Refining the American guidelines for prevention of cardiovascular disease
  William E. Feeman> ;Lancet. 2014 Feb 15
• Statins do lower cardiovascular mortality.
  William E. Feeman> ;Journal of Clinical Lipidology. 2013 Sep 1
• High HDL and ATD.
  W.E. Feeman> ;Journal of Clinical Lipidology. 2012 Jan 1
• Inflammation and atherothrombotic disease.
  William E. Feeman> ;The American Journal of Cardiology. 2011 Oct 15
• The combined effect of hypothyroidism and hyperlipoproteinemia.
  William E. Feeman> ;Journal of Clinical Lipidology. 2011 Jan 1
• 1 citations
  Diabetes mellitus is not a coronary heart disease equivalent.
  W.E. Feeman> ;The American Journal of Cardiology. 2010 Sep 1
• Prevention of atherothrombotic disease (ATD).
  Feeman WE> ;J Clin Lipidol. 2010-01-01
• 2 citations
  Treating Lipids in the General Population
  William E. Feeman> ;The American Journal of Cardiology. 2008 Aug 1
• Statins and diabetes.
  William E. Feeman> ;Lancet. 2008 May 24
• 4 citations
  Statin-fibrate combination therapy.
  William E. Feeman> ;The American Journal of Cardiology. 2008 May 15
• Associated atherothrombotic disease risk factors in diabetes and prediabetes.
  William E. Feeman> ;The American Journal of Medicine. 2006 May 1
• National cholesterol education program (NCEP) guidelines too complex.
  William E Feeman> ;Preventive Cardiology. 2005 Jan 1
• 9 citations
  Prediction of the population at risk for atherothrombotic disease.
  William E. Feeman> ;Experimental and Clinical Cardiology. 2004 Jan 1
• 50 citations
  Serum Creatinine Concentrations in Retired Racing Greyhounds
  William E. Feeman, C. Guillermo Couto, Toni L. Gray> ;Veterinary Clinical Pathology. 2003 Mar 1
• 7 citations
  Prediction of Angiographic Stabilization/Regression of Coronary Atherosclerosis by a Risk Factor Graph
  William E. Feeman, Josef Niebauer> ;Journal of Cardiovascular Risk. 2000 Dec 1
• 17 citations
  The role of cigarette smoking in atherosclerotic disease: an epidemiologic analysis.
  William E. Feeman> ;Journal of Cardiovascular Risk. 1999 Oct 1
• Dyslipidemic hypertension.
  Feeman WE> ;J Fam Pract. 1994-05-01
• Join now to see all

Journal Articles

• Atherothrombotic Disease Risk Factors in Youth  
  W.E.Feeman,Jr,MD, Journal of Pediatric Health Care and Medicine, 3/28/2022
• Prediction of the Population at Risk of Atherothrombotic Disease: A Three Step Approach  
  W.E.Feeman,Jr,MD, Cardiology Research and Reports, 1/4/2022
• Comparing Predictions of Athrothrombotic Disease Risk in Women Versus Men  
  W.E.Feeman,Jr,MD, Journal of Heart, 6/21/2021
• Angiographic Outcomes When Target Goals of Lipid Modifying Therapy Are Not Met  
  W.E.Feeman,Jr,MD, International Journal of Research Studies in Medical and Health Sciences, 6/2021
• Type II Hyerlipoproteinemia in a Woman with Intially Normal Low-Density Lipoprotein Cholesterol  
  W.E.Feeman,Jr,MD, EC Cinical and Medical Case Reports, 4/2021
• Patient Receiving Statin Therapy Achieves an Age of 100 Years: Report of a Case  
  W.E.Feeman, Jr,MD, EC Clinical and Medcal Case Reports, 12/31/2020
• Lipid Risk Factors in Atherothrombotic Disease: Is the Cholesterol Retention Fraction Better Than Low0density Lipoprotein Cholesterol?B  
  W.E.Feeman,Jr,MD, Singapore Jouranl of Cardiology, 12/12/2020
• Risk factors fr Atherothrombotic Disease: A Suggested Rank Order  
  W.E.Feeman,Jr,MD, EC Cardiology, 10/30/2020
• Enhanced Prediction of the Population at Risk of Atherothrombotic Disease: Back to Framingham  
  W.E.Feeman,Jr,MD, EC Cardiology, 2/12/2020
• Statin Therapy in a 102 Year Old Survivor of Myocardial Infarction: Statin Therapy in Extreme Old Age  
  W.E.Feeman,Jr,MD, Cardiovascular Investigations, 12/1/2017
• Concerns About the Use of Non-High-Density Lipoprotein Cholesterol as a Lipid Predictor  
  W.E.Feeman,Jr,MD, European Medical Journal (Cardiology), 4/2016
• The Program on urgical Control of theHyperlipidemias (POSCH) and the Lipid Regulatory Hypothesis  
  W.E.Feeman,Jr,MD, European Medical Journal, 3/2015
• LDL Lowering: Evidence for a Plaque Non-Prgression Threshold  
  W.E.Feeman,Jr,MD, International Journal of Cardiovascular Research, 9/26/2013
• Prediction of Angiographic Stabilization/Regression of Coronary Atherosclerosis by a Risk Factor Graph  
  W.E.Feeman,Jr,MD, Journal of cardiovascular Risk, 12/2000
• The Role of Cigarette Smoking in Atherosclerotic Disease  
  W.E.Feeman,Jr,MD, Journal of Cardiovascular Disease, 10/1999
• Join now to see all